4.6 Review

RBM24 in the Post-Transcriptional Regulation of Cancer Progression: Anti-Tumor or Pro-Tumor Activity?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

RNA-Binding motif protein 38 (RBM38) mediates HBV pgRNA packaging into the nucleocapsid

Yongxuan Yao et al.

Summary: This study demonstrates that RBM38 interacts with epsilon, pol, RBM24, and HBV core to mediate pgRNA packaging. It directly binds to epsilon via RNA recognition submotifs and interacts with HBV Pol in an RNA-independent manner. Additionally, RBM38 binds to the HBV core protein and facilitates the combination of Pol-epsilon with the HBV core protein.

ANTIVIRAL RESEARCH (2022)

Article Oncology

Comprehensive Analysis of Alternative Splicing in Gastric Cancer Identifies Epithelial-Mesenchymal Transition Subtypes Associated with Survival

Yukyung Jun et al.

Summary: This study provides a comprehensive analysis of the significance of alternative splicing in patient classification, molecular mechanisms, and prognosis in gastric cancer.

CANCER RESEARCH (2022)

Article Oncology

RNA-binding proteins: Underestimated contributors in tumorigenesis

Y. Zhao et al.

Summary: mRNA stability is regulated by RNA-binding proteins (RBPs), which play a crucial role in tumorigenesis, cancer prognosis, diagnosis, and treatment. RBPs interact with oncogenes and tumor suppressor genes, affecting various cellular functions such as apoptosis, cell proliferation, and immune response. This review provides insights into the influence of RBP mutations on tumorigenesis and updates the current understanding of how RBPs regulate cancer.

SEMINARS IN CANCER BIOLOGY (2022)

Review Oncology

Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances

Blanca Cucarull et al.

Summary: Hepatocellular carcinoma (HCC) is the most common form of liver cancer with poor prognosis and increasing incidence. Recent advances in systemic treatment options, including tyrosine kinase inhibitors, antiangiogenic antibodies, and immune checkpoint inhibitors, have provided hope for HCC patients. Understanding the specific molecular mechanisms that influence tumor growth and immune control in HCC is crucial for physician decision-making and developing effective treatments.

CANCERS (2022)

Article Oncology

Prognostic significance of SNCA and its methylation in bladder cancer

Zhengcun Wu et al.

Summary: This study investigates the role of SNCA gene in bladder cancer (BLCA) and its potential as a prognostic diagnostic biomarker. The results show that SNCA is downregulated in BLCA tumor tissues and is negatively correlated with DNA methylation. High SNCA expression is associated with poor overall survival. SNCA is also found to play a role in immune cell infiltration, particularly with T cells. Therefore, SNCA may serve as a promising prognostic biomarker in BLCA patients.

BMC CANCER (2022)

Review Biochemistry & Molecular Biology

RBM38 in cancer: role and mechanism

Cheng Zou et al.

Summary: RBPs are widely dysregulated in numerous human cancers, and RBM38, as a well-studied RBP, frequently plays a tumor-suppressive role in multiple human cancer types. By uncovering a spectrum of transcripts bound by RBM38, the diversity in its mechanisms of action in distinct biological contexts can be revealed, indicating the possibility of targeting RBM38 and its related pathways as therapeutic strategies against cancer.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Article Cell Biology

Identification of a novel tumour microenvironment-based prognostic biomarker in skin cutaneous melanoma

Rong-Hua Yang et al.

Summary: By analyzing the TME in SKCM using different algorithms and methods, multiple reliable prognostic genes were identified, among which PRSS35 was confirmed as a novel TME-based prognostic biomarker. Functional analysis indicated that PRSS35 may act as a potential prognostic biomarker in SKCM.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

RNA-binding protein RBM24 represses colorectal tumourigenesis by stabilising PTEN mRNA

Rong Mu Xia et al.

Summary: The study reveals that RBM24 is expressed at lower levels in colorectal tumors, Rbm24-knockout mice develop spontaneous adenomas, RBM24 can stabilize PTEN mRNA, inhibit proliferation, migration, and invasion of CRC cells.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Article Multidisciplinary Sciences

Rbm24 displays dynamic functions required for myogenic differentiation during muscle regeneration

Raphaelle Grifone et al.

Summary: Rbm24 plays multiple roles in muscle regeneration by regulating myogenic differentiation and muscle-specific pre-mRNA alternative splicing. It is rapidly upregulated in regenerating myofibers post-injury and shows nuclear localization in nascent myofibers.

SCIENTIFIC REPORTS (2021)

Article Oncology

Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers

Yiduo Liu et al.

Summary: This study identified potential biomarkers for TNBC through bioinformatics analysis. Four genes were identified as prognostic signatures in the disease-free interval, while five genes were associated with the progression-free interval. Time-dependent ROC analysis indicated that the multivariate Cox regression models based on these genes had great predictive performance. Additionally, FAM83B was found to significantly affect the prognosis of patients in different TNBC subtypes.

BMC CANCER (2021)

Article Oncology

miR-383 increases the cisplatin sensitivity of lung adenocarcinoma cells through inhibition of the RBM24-mediated NF-κB signaling pathway

Bo He et al.

Summary: The downregulation of miR-383 leads to increased expression of RBM24 protein in lung adenocarcinoma cells, which activates chemotherapy resistance through NF-kappa B signaling pathway. The study provides potential therapeutic targets for clinical reversal of chemotherapy resistance in lung adenocarcinoma.

INTERNATIONAL JOURNAL OF ONCOLOGY (2021)

Article Gastroenterology & Hepatology

TPRG1-AS1 induces RBM24 expression and inhibits liver cancer progression by sponging miR-4691-5p and miR-3659

Ji-Hye Choi et al.

Summary: Through RNA-Seq analysis, the study identified TPRG1-AS1 as a potential driver noncoding RNA that promotes heterogeneous progression of liver cancer. TPRG1-AS1 induces tumor suppressor RBM24, activating apoptotic tumor cell death to suppress tumor growth, and acts as a ceRNA interfering with the binding of miR-4691-5p and miR-3659 to RBM24.

LIVER INTERNATIONAL (2021)

Article Oncology

Tumor suppressor RBM24 inhibits nuclear translocation of CTNNB1 and TP63 expression in liver cancer cells

Sung Ung Moon et al.

Summary: RBM24 functions as a tumor suppressor in liver cancer cells by inhibiting nuclear translocation of beta-catenin and tumor protein 63 expression, as well as suppressing sphere formation in liver cancer cells. It is hypothesized to be a potential novel therapeutic target for liver cancer treatment.

ONCOLOGY LETTERS (2021)

Article Oncology

Classifying Medulloblastoma Subgroups Based on Small, Clinically Achievable Gene Sets

Sivan Gershanov et al.

Summary: The study used machine learning to extract reliable gene sets to distinguish between the four subgroups of medulloblastoma, which can be reduced to only six genes from the known NanoString 22-gene set without compromising accuracy. This identified gene set is small enough to make a qPCR-based subgroup classification easily accessible to clinicians, even in developing, poorly equipped countries.

FRONTIERS IN ONCOLOGY (2021)

Review Cell Biology

RNA-Binding Proteins in the Post-transcriptional Control of Skeletal Muscle Development, Regeneration and Disease

De-Li Shi et al.

Summary: Embryonic myogenesis is a complex process regulated by RNA-binding proteins, which play a crucial role in controlling different steps to ensure the proliferation and differentiation of muscle cells. Dysfunctions of RNA-binding proteins can affect muscle development and homeostasis, leading to defects in motor neurons or the neuromuscular junction, resulting in muscle degeneration and neuromuscular disease.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

RBM24 exacerbates bladder cancer progression by forming a Runx1t1/TCF4/miR-625-5p feedback loop

Yue-Wei Yin et al.

Summary: RBM24 regulates bladder cancer progression by positively regulating Runx1t1 expression, forming a positive feedback loop that drives cancer cell proliferation. Interrupting this feedback loop may be a potential therapeutic strategy for treating bladder cancer.

EXPERIMENTAL AND MOLECULAR MEDICINE (2021)

Article Biochemistry & Molecular Biology

A comprehensive expression landscape of RNA-binding proteins (RBPs) across 16 human cancer types

Bin Zhang et al.

RNA BIOLOGY (2020)

Article Cell Biology

Understanding and targeting the disease-related RNA binding protein human antigen R (HuR)

Christopher W. Schultz et al.

WILEY INTERDISCIPLINARY REVIEWS-RNA (2020)

Article Gastroenterology & Hepatology

Global Burden of 5 Major Types of Gastrointestinal Cancer

Melina Arnold et al.

GASTROENTEROLOGY (2020)

Article Multidisciplinary Sciences

Rbm24 controls poly(A) tail length and translation efficiency of crystallin mRNAs in the lens via cytoplasmic polyadenylation

Ming Shao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Letter Biochemistry & Molecular Biology

Loss of Rbm24a causes defective hair cell development in the zebrafish inner ear and neuromasts

Xiaoning Cheng et al.

JOURNAL OF GENETICS AND GENOMICS (2020)

Review Oncology

RNA-binding proteins in tumor progression

Hai Qin et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Article Biochemistry & Molecular Biology

Circular RNA SMARCA5 suppressed non-small cell lung cancer progression by regulating miR-670-5p/RBM24 axis

Danjie Zhang et al.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2020)

Review Pharmacology & Pharmacy

Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer

Shakur Mohibi et al.

PHARMACOLOGY & THERAPEUTICS (2019)

Review Medicine, General & Internal

Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

Narjust Duma et al.

MAYO CLINIC PROCEEDINGS (2019)

Article Biochemistry & Molecular Biology

Transcriptome alterations in myotonic dystrophy skeletal muscle and heart

Eric T. Wang et al.

HUMAN MOLECULAR GENETICS (2019)

Article Biochemistry & Molecular Biology

Mutational landscape of RNA-binding proteins in human cancers

Yaseswini Neelamraju et al.

RNA BIOLOGY (2018)

Article Biochemistry & Molecular Biology

Rbm24, a target of p53, is necessary for proper expression of p53 and heart development

Min Zhang et al.

CELL DEATH AND DIFFERENTIATION (2018)

Article Anatomy & Morphology

Expression Patterns of Rbm24 in Lens, Nasal Epithelium, and Inner Ear During Mouse Embryonic Development

Raphaelle Grifone et al.

DEVELOPMENTAL DYNAMICS (2018)

Review Oncology

Pleiotropic Roles for ZEB1 in Cancer

Julie Caramel et al.

CANCER RESEARCH (2018)

Review Biochemistry & Molecular Biology

Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer

Ines Marmol et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Multidisciplinary Sciences

Stk38 Modulates Rbm24 Protein Stability to Regulate Sarcomere Assembly in Cardiomyocytes

Jing Liu et al.

SCIENTIFIC REPORTS (2017)

Review Oncology

RNA-Binding Proteins in Cancer: Old Players and New Actors

Bruno Pereira et al.

TRENDS IN CANCER (2017)

Article Cell Biology

Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds

Ludovic Arandel et al.

DISEASE MODELS & MECHANISMS (2017)

Article Biochemistry & Molecular Biology

CPEB1 mediates epithelial-to-mesenchyme transition and breast cancer metastasis

K. Nagaoka et al.

ONCOGENE (2016)

Review Neurosciences

Roles for RNA-binding proteins in development and disease

Amy E. Brinegar et al.

BRAIN RESEARCH (2016)

Article Medicine, Research & Experimental

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer

Jill E. Larsen et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Multidisciplinary Sciences

Lineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers

Eva Perez-Guijarro et al.

NATURE COMMUNICATIONS (2016)

Review Cell Biology

Advances in the characterization of RNA-binding proteins

Domenica Marchese et al.

WILEY INTERDISCIPLINARY REVIEWS-RNA (2016)

Article Cell Biology

RBM24 Is a Major Regulator of Muscle-Specific Alternative Splicing

Jiwen Yang et al.

DEVELOPMENTAL CELL (2014)

Article Biochemistry & Molecular Biology

Rbm24, an RNA-binding Protein and a Target of p53, Regulates p21 Expression via mRNA Stability

Yuqian Jiang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Oncology

RNA-Binding Protein RBM24 Regulates p63 Expression via mRNA Stability

Enshun Xu et al.

MOLECULAR CANCER RESEARCH (2014)

Review Genetics & Heredity

A census of human RNA-binding proteins

Stefanie Gerstberger et al.

NATURE REVIEWS GENETICS (2014)

Article Multidisciplinary Sciences

Mice deficient in Rbm38, a target of the p53 family, are susceptible to accelerated aging and spontaneous tumors

Jin Zhang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Review Biochemistry & Molecular Biology

microRNAs and RNA-binding proteins A complex network of interactions and reciprocal regulations in cancer

Silvia Anna Ciafre et al.

RNA BIOLOGY (2013)

Review Cell Biology

The CPEB-family of proteins, translational control in senescence and cancer

Gonzalo Fernandez-Miranda et al.

AGEING RESEARCH REVIEWS (2012)

Article Cardiac & Cardiovascular Systems

RNA-binding protein RBM24 is required for sarcomere assembly and heart contractility

Kar Lai Poon et al.

CARDIOVASCULAR RESEARCH (2012)

Article Developmental Biology

Identification of RNA binding motif proteins essential for cardiovascular development

Samantha Maragh et al.

BMC DEVELOPMENTAL BIOLOGY (2011)

Review Biochemistry & Molecular Biology

p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53

G. Melino

CELL DEATH AND DIFFERENTIATION (2011)

Review Oncology

MicroRNA regulation by RNA-binding proteins and its implications for cancer

Marieke van Kouwenhove et al.

NATURE REVIEWS CANCER (2011)

Article Biotechnology & Applied Microbiology

Rapid and systematic analysis of the RNA recognition specificities of RNA-binding proteins

Debashish Ray et al.

NATURE BIOTECHNOLOGY (2009)

Review Biochemistry & Molecular Biology

RNA-binding proteins and post-transcriptional gene regulation

Tina Glisovic et al.

FEBS LETTERS (2008)

Review Genetics & Heredity

RNA-binding proteins in human genetic disease

Kiven E. Lukong et al.

TRENDS IN GENETICS (2008)

Article Biochemistry & Molecular Biology

Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma

Jeffrey S. Chamberlain et al.

FASEB JOURNAL (2007)